HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function.

Abstract
The ability of cardiac stem cells (CSCs) to promote myocardial repair under clinically relevant conditions (i.e., when delivered intravascularly after reperfusion) is unknown. Thus, rats were subjected to a 90-min coronary occlusion; at 4 h after reperfusion, CSCs were delivered to the coronary arteries via a catheter positioned into the aortic root. Echocardiographic analysis showed that injection of CSCs attenuated the increase in left ventricular (LV) end-diastolic dimensions and impairment in LV systolic performance at 5 weeks after myocardial infarction. Pathologic analysis showed that treated hearts exhibited a smaller increase in LV chamber diameter and volume and a higher wall thickness-to-chamber radius ratio and LV mass-to-chamber volume ratio. CSCs induced myocardial regeneration, decreasing infarct size by 29%. A diploid DNA content and only two chromosomes 12 were found in new cardiomyocytes, indicating that cell fusion did not contribute to tissue reconstitution. In conclusion, intravascular injection of CSCs after reperfusion limits infarct size, attenuates LV remodeling, and ameliorates LV function. This study demonstrates that CSCs are effective when delivered in a clinically relevant manner, a clear prerequisite for clinical translation, and that these beneficial effects are independent of cell fusion. The results establish CSCs as candidates for cardiac regeneration and support an approach in which the heart's own stem cells could be collected, expanded, and stored for subsequent therapeutic repair.
AuthorsBuddhadeb Dawn, Adam B Stein, Konrad Urbanek, Marcello Rota, Brian Whang, Raffaella Rastaldo, Daniele Torella, Xian-Liang Tang, Arash Rezazadeh, Jan Kajstura, Annarosa Leri, Greg Hunt, Jai Varma, Sumanth D Prabhu, Piero Anversa, Roberto Bolli
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 102 Issue 10 Pg. 3766-71 (Mar 08 2005) ISSN: 0027-8424 [Print] United States
PMID15734798 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Animals
  • Cell Fusion
  • Cell Movement
  • Echocardiography
  • Myocardial Infarction (pathology, physiopathology, therapy)
  • Myocardium (pathology)
  • Myocytes, Cardiac (cytology, physiology)
  • Rats
  • Rats, Inbred F344
  • Regeneration
  • Stem Cell Transplantation
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: